Literature DB >> 11020799

Inhibitory effect of cystic fibrosis sputum on adenovirus-mediated gene transfer in cultured epithelial cells.

M A Perricone1, D D Rees, C R Sacks, K A Smith, J M Kaplan, J A St George.   

Abstract

Effective gene transfer to the airway epithelial cells of individuals with cystic fibrosis (CF) requires gene therapy vectors to effectively penetrate the mucous lining of the airways of these patients. In this study, we examined the effects of the aqueous sol fraction of sputum recovered from CF patients (CF sol) on adenovirus (Ad)-mediated gene transfer to cultured epithelial cells. Sputum collected from patients with CF was separated into aqueous sol and gel fractions by ultracentrifugation and the sol fraction from different individuals was pooled. To determine if CF sol affects Ad-mediated transfection, Fisher rat thyroid (FRT) epithelial cells or normal human bronchial epithelial (NHBE) cells were infected with an Ad encoding beta-galactosidase (Ad2/betagal-2) in the presence or absence of the pooled CF sol. Transfection efficiency was determined by measuring beta-Gal activity. CF sol significantly inhibited Ad2-mediated gene transfer in a dose-dependent manner when the vector was incubated with CF sol prior to exposure to the cells. In contrast, preincubation of the cells with the sol was without effect. The inhibition of Ad-mediated gene transfer by CF sol was not related to its low pH, was abrogated by preadsorption with an Ad2 serotype vector, and was neutralized by heat treatment, but was not affected by treatment with protease inhibitors. Analysis of CF sol fractions from seven different individuals with CF showed inhibition of Ad-mediated gene transfer in four of the seven samples tested and, further, the inhibitory effect was correlated with the presence of Ad-specific antibodies. We conclude that preexisting adenovirus-specific antibodies present in some of the patient samples were the predominant factor inhibiting Ad-mediated gene transfer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11020799     DOI: 10.1089/10430340050143426

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  11 in total

Review 1.  Immunological hurdles to lung gene therapy.

Authors:  S Ferrari; U Griesenbach; D M Geddes; E Alton
Journal:  Clin Exp Immunol       Date:  2003-04       Impact factor: 4.330

2.  On the transport of lipoplexes through cystic fibrosis sputum.

Authors:  Niek N Sanders; Elsa Van Rompaey; Stefaan C De Smedt; Joseph Demeester
Journal:  Pharm Res       Date:  2002-04       Impact factor: 4.200

3.  Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.

Authors:  C P Rooney; G M Denning; B P Davis; D M Flaherty; J A Chiorini; J Zabner
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

4.  N-acylhomoserine lactones undergo lactonolysis in a pH-, temperature-, and acyl chain length-dependent manner during growth of Yersinia pseudotuberculosis and Pseudomonas aeruginosa.

Authors:  Edwin A Yates; Bodo Philipp; Catherine Buckley; Steve Atkinson; Siri Ram Chhabra; R Elizabeth Sockett; Morris Goldner; Yves Dessaux; Miguel Cámara; Harry Smith; Paul Williams
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

Review 5.  Current status of gene therapy for inherited lung diseases.

Authors:  Ryan A Driskell; John F Engelhardt
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

Review 6.  Gene Therapy for Acute Respiratory Distress Syndrome.

Authors:  Jing Liu; David A Dean
Journal:  Front Physiol       Date:  2022-01-17       Impact factor: 4.566

7.  Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients.

Authors:  Kaoru Hida; Samuel K Lai; Jung Soo Suk; Sang Y Won; Michael P Boyle; Justin Hanes
Journal:  PLoS One       Date:  2011-05-27       Impact factor: 3.240

8.  Magnetofection Enhances Lentiviral-Mediated Transduction of Airway Epithelial Cells through Extracellular and Cellular Barriers.

Authors:  Stefano Castellani; Clara Orlando; Annalucia Carbone; Sante Di Gioia; Massimo Conese
Journal:  Genes (Basel)       Date:  2016-11-23       Impact factor: 4.096

Review 9.  Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis.

Authors:  Stefano Ferrari; Duncan M Geddes; Eric W F W Alton
Journal:  Adv Drug Deliv Rev       Date:  2002-12-05       Impact factor: 15.470

Review 10.  Extracellular barriers in respiratory gene therapy.

Authors:  Niek Sanders; Carsten Rudolph; Kevin Braeckmans; Stefaan C De Smedt; Joseph Demeester
Journal:  Adv Drug Deliv Rev       Date:  2008-12-24       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.